Robotic-assisted right hepatectomy via anterior approach for intrahepatic cholangiocarcinoma

Goja, Sanjay; Singh, Manoj Kumar; Chaudhary, Rohan Jagat; Soin, Arvinder S.

doi:10.14701/ahbps.2017.21.2.80

Cited by 5 publications

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All reviewers approved of the final set of included studies. In total, 11 studies reported data on 146 patients undergoing robotic surgery for cholangiocarcinoma (CC) [ 5 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 ], and 10 studies reported data on 113 patients undergoing robotic surgery for gallbladder cancer (GBC) [ 6 , 15 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ].…”

Section: Resultsmentioning

confidence: 99%

Robotic Surgery for Biliary Tract Cancer

Kone

Bystrom

Maker

2022

Cancers

View full text Add to dashboard Cite

Biliary tract cancer consists of cholangiocarcinoma (CC) and gallbladder cancer (GBC). When resectable, surgery provides the best chance at long-term survival. Unfortunately, surgery for these tumors is associated with long operative times, high morbidities, and prolonged hospital stays. Minimally invasive surgery has been shown to impact selected outcomes, including length of stay, in other diseases, and robotic surgery may offer additional advantages compared to laparoscopic surgery in treating bile duct cancers. This is a systematic review of robotic surgery for biliary tract cancer. Predetermined selection criteria were used to appraise the literature. The PRISMA guidelines were followed. In total, 20 unique articles with a total of 259 patients with biliary tract cancer undergoing robotic surgery met the inclusion criteria. For CC and GBC, respectively, the weighted average operative time was 401 and 277 min, the estimated blood loss was 348 and 260 mL, the conversion rate to open was 7 and 3.5%, the all-cause morbidity was 52 and 9.7%, the major morbidity was 12 and 4.4%, the perioperative mortality was 1.4 and 0%, the length of stay was 15 and 4.8 days, the positive margin rate was 27 and 9%, and the number of lymph nodes retrieved was 4.2 and 8. Robotic surgery for biliary tract cancer appears non-inferior to open surgery when compared to the published contemporary data. However, the current literature on the topic is of low quality, and future prospective/randomized studies are needed.

show abstract

Section: Resultsmentioning

confidence: 99%

Robotic Surgery for Biliary Tract Cancer

Kone

Bystrom

Maker

2022

Cancers

View full text Add to dashboard Cite

show abstract

“…Finally, few data are available on robotic liver resection for intra-hepatic cholangiocarcinoma, and no significant data on oncological outcomes are currently available (16,19,20).…”

Section: Primary Liver Tumorsmentioning

confidence: 99%

Robotic liver resection: Hurdles and beyond

Benedetto

Petrowsky

Magistri

et al. 2020

International Journal of Surgery

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract